Centogene
Business Services · Germany · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Am Strande 7, Rostock, Mecklenburg-Weste...Phone Number
+49 38180113416Website
www.centogene.comRevenue
$48.5 MillionStock Symbol
CNTGIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
2
1
1
About Centogene
Centogene N.V., together with its subsidiaries, provides pharmaceutical solutions and diagnostic tests in Europe, the Middle East, North America, Latin America, and the Asia Pacific. The company offers data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It provides CENTOGENE MOx 2.0, a single-step multiomic solution that combines DNA sequencing, biochemical testing, and RNA sequencing; CentoCloud, a cloud-based Software as a Service platform, which enables laboratories to analyze, interpret, and report genomic variants for rare disease diagnostics; FilterTool, a web-based application for genetic data interpretation; and NEW CentoGenome, a Next Generation Sequencing (NGS)-based assay that provides diagnostic information to accelerate access to potential treatment options.Explore more
Centogene Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Centogene your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Centogene is spiking on competitors!
Product Launch: Get notified when Centogene launches new products
Funding: Get notified immidiatlly once Centogene has new funding data
Earning: See what the market has to say on Centogene recently announced quarterly report
Click to see if Centogene had a recent Job posting/layoffs
Centogene, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Centogene
Check if Centogene has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Centogene is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Centogene is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Centogene.
Centogene financials insights
Gather financial insights about Centogene, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Series A
$28M
2019
Stock Offering
$56M
2022
Debt
$45M
Share Placement
$17M
Centogene Tech Stack
A closer look at the technologies used by Centogene
See more technologies
Most Recent Scoops
Open Position
Event
Product Marketing, Events, Sales, Search, Laboratory Operations, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
Open Position
Hiring Plans
Centogene has more open roles in Operations than it has had at any time in the past 12 months.
Hiring Plans
Hiring Plans
Hiring Plans
Centogene News & Media
CENTOGENE Announces Voting Results of Extraordinary General Meeting
Approval of All Resolutions, Including Announced Transaction With Charme Capital Partners Approval of All Resolutions, Including Announced Transaction With Charme Capital PartnersCENTOGENE Signs Strategic Transaction With Private Equity Group Charme Capital Partners
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (OTC: CNTGF) (“CENTOGENE” or the “Company”), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced it has concluded its strategic review process and has entered into a Share Purchase Agreement (“SPA”) pursuant to which its operating subsidiaries will be sold to an affiliate of Charme Capital Partners Limited (“Charme”), a pan-European priCENTOGENE Data on Novel Genetic Risk Factor for Parkinson’s Disease in The Lancet Neurology
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Centogene N.V., the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced data from the Company’s Rostock International Parkinson's Disease (ROPAD), further supporting the association of a RAB32 gene mutation with Parkinson's disease (PD). The study, published in The Lancet Neurology, builds on research from Emil K. Gustavsson and colleagues, who previouslCentogene N.V. Supervisory Board Reshuffle and CFO Talks - TipRanks.com
Centogene (CNTGF) has released an update. Key members of the Centogene N.V. Supervisory Board, including Peer Schatz, Mary Sheahan, and Jonathan Sheldon, are set to...
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Centogene
Sign Up For FreeTo access detailed company insights
Centogene N.V., together with its subsidiaries, provides pharmaceutical solutions and diagnostic tests in Europe, the Middle East, North America, Latin America, and the Asia Pacific. The company offers data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It provides CENTOGENE MOx 2.0, a... Read More
